Insider Selling: NEXGEL, Inc. (NASDAQ:NXGL) Director Sells 3,000 Shares of Stock

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the company’s stock in a transaction dated Friday, December 20th. The stock was sold at an average price of $4.64, for a total transaction of $13,920.00. Following the transaction, the director now owns 144,553 shares of the company’s stock, valued at approximately $670,725.92. This trade represents a 2.03 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

NEXGEL Price Performance

NXGL stock traded down $0.07 during trading on Monday, hitting $4.66. The stock had a trading volume of 82,959 shares, compared to its average volume of 49,195. The company’s 50-day moving average price is $3.38 and its two-hundred day moving average price is $2.82. NEXGEL, Inc. has a twelve month low of $1.84 and a twelve month high of $5.10. The stock has a market capitalization of $31.65 million, a P/E ratio of -8.03 and a beta of 0.76. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.51 and a quick ratio of 0.93.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in NEXGEL stock. Northeast Financial Group Inc. raised its holdings in shares of NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,848 shares of the company’s stock after buying an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned about 0.50% of NEXGEL worth $82,000 as of its most recent SEC filing. Institutional investors own 2.21% of the company’s stock.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.